# Study Comparing Ticagrelor With Aspirin for Prevention of Vascular Events in Patients Undergoing CABG

Study · id `cardio:ct-nct01755520` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01755520](<https://clinicaltrials.gov/study/NCT01755520>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01755520

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 1893 participants.

## Technical summary

Registry record NCT01755520. Randomized; quadruple masking; primary purpose treatment. Start 2013-04-24 (registry gives no type); primary completion 2018-05-19 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 1893 participants (enrolled count; ClinicalTrials.gov record NCT01755520, source copy `cardio:ctgov-nct01755520-2018-08-02`, retrieved 2026-10-26)
- Start date: 2013-04-24 (registry gives no type) (ClinicalTrials.gov record NCT01755520, source copy `cardio:ctgov-nct01755520-2018-08-02`, retrieved 2026-10-26)
- Primary completion: 2018-05-19 (actual) (ClinicalTrials.gov record NCT01755520, source copy `cardio:ctgov-nct01755520-2018-08-02`, retrieved 2026-10-26)
- Completion: 2018-05-19 (actual) (ClinicalTrials.gov record NCT01755520, source copy `cardio:ctgov-nct01755520-2018-08-02`, retrieved 2026-10-26)
- Countries: Austria; Germany; Switzerland (ClinicalTrials.gov record NCT01755520, source copy `cardio:ctgov-nct01755520-2018-08-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01755520-2018-08-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study Comparing Ticagrelor With Aspirin for Prevention of Vascular Events in Patients Undergoing CABG
- Acronym: TiCAB
- Condition: Coronary Artery Disease
- Condition: Stable Angina
- Condition: Acute Coronary Syndrome
- Intervention (Drug): Ticagrelor
- Intervention (Drug): Aspirin
- Intervention (Drug): Placebo - Ticagrelor
- Intervention (Drug): Placebo - Aspirin
- Lead sponsor: Deutsches Herzzentrum Muenchen
- Lead sponsor class: OTHER
- Collaborator: AstraZeneca
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Stable angina (`cardio:stable-angina`)
- Registry intervention name matches this record: Ticagrelor (`cardio:ticagrelor`)
- Registry intervention name matches this record: Aspirin (`core:aspirin`)
- Registry lists this organization as the lead sponsor: Deutsches Herzzentrum Muenchen (`cardio:org-deutsches-herzzentrum-muenchen`)
- Registry lists this organization as a collaborator: AstraZeneca (`cardio:astrazeneca`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Randomized trial of ticagrelor vs. aspirin in patients after coronary artery bypass grafting: the TiCAB trial (`cardio:pubmed-31145798`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 607b2f3427771a18557ad32a07a0682afdd4f3f33bdd9f32aff18363870a25da
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
